Cytokinetics, Incorporated
USD87.31
+0.05 (+0.06%)
CEO
Robert I. Blum
IPO Date
2004-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$87.77
Prev. Close
$87.26
Day Low
$86.55
Day High
$88.31
52W Low
$32.66
52W High
$88.31
Market Cap
$10.86B
Volume
0.21M
| -8.9 |
| 31 Dec 2023 | FY | -4284.1% | -6988.6% | 136.2% | -63.8% | -1.96 | 6.12 | -15.3 |
| 31 Dec 2022 | FY | -154.6% | -411.2% | 360.5% | -38.3% | -6.95 | 9.40 | -10.6 |
| 31 Dec 2021 | FY | -127.1% | -305.7% | -88.3% | -25.6% | 1.11 | 7.45 | -16.3 |
| 31 Dec 2020 | FY | -73.7% | -228.0% | -112.3% | -23.8% | 1.23 | 15.20 | -10.5 |
| 31 Dec 2019 | FY | -220.5% | -452.9% | 1112.7% | -42.0% | -12.44 | 8.98 | -5.0 |
| 31 Dec 2018 | FY | -183.0% | -337.4% | -409.8% | -50.3% | 1.64 | 9.36 | -3.2 |
| 31 Dec 2017 | FY | -575.5% | -955.9% | -116.3% | -43.3% | 0.29 | 8.45 | -3.2 |
| 31 Dec 2016 | FY | 39.5% | 15.5% | 17.4% | 9.7% | 0.29 | 4.77 | 29.5 |
| -10.6 |
| 30 Sept 2025 | Q3 | -38.4% | -15815.0% | 58.8% | -21.3% | -2.30 | 6.88 | -5.4 |
| 30 Jun 2025 | Q2 | 96.6% | -201.2% | 36.4% | -11.0% | -2.33 | 6.76 | -7.3 |
| 31 Mar 2025 | Q1 | -6223.1% | -10220.1% | 60.6% | -12.8% | -2.97 | 5.99 | -7.4 |
| 31 Dec 2024 | Q4 | -453.1% | -886.3% | 110.8% | -10.7% | -5.83 | 6.17 | -9.3 |
| 30 Sept 2024 | Q3 | -18174.7% | -34674.9% | 1154.1% | -11.2% | -56.76 | 9.28 | -9.7 |
| 30 Jun 2024 | Q2 | -31866.7% | -57557.4% | -132.0% | -9.4% | 7.28 | 10.39 | -10.4 |
| 31 Mar 2024 | Q1 | -9668.9% | -16244.7% | 34.2% | -16.8% | -1.91 | 7.19 | -13.7 |
| 31 Dec 2023 | Q4 | -4982.3% | -8187.6% | 35.4% | -16.6% | -1.96 | 6.12 | -15.1 |